557NewsAlibaba Pictures and Studio Ghibli Forge Strategic Partnership
HONG KONG SAR – Media OutReach Newswire – 24 January 2024 – On January 5, 2024, Alibaba Pictures Group Limited (“Alibaba Pictures”...
- 352News
DHL Global Forwarding Asia Pacific earns Top Employer status for the fifth consecutive year
Eight countries across the region have been certified as Top Employer SINGAPORE – Media OutReach Newswire – 24 January 2024 – DHL...
- 532News
Salaries in Malaysia Projected to Remain Flat in 2024 Amidst Economic Slowdown Concerns, Aon Survey
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 24 January 2024 – Aon plc (NYSE: AON), a leading global professional services firm,...
- 348Wire Stories
Rio Tinto Statement – Plane crash near Fort Smith, Northwest Territories, Canada
MELBOURNE, Australia–(BUSINESS WIRE)–We have been informed by authorities that a plane on its way to our Diavik mine, carrying a number of...
- 417News
Experienced the Exquisite Flavor of European Canned Peaches in Ho Chi Minh City
HO CHI MINH CITY, VIETNAM – Media OutReach Newswire – 24 January 2024 – An exclusive Product Presentation took place on Thursday,...
- 432News
The Chinese University of Hong Kong (CUHK) Showcases Dynamic Student Experiences in Diverse Postgraduate Programmes
HONG KONG SAR – Media OutReach Newswire – 24 January 2024 – The Chinese University of Hong Kong (CUHK) takes pride in...
- 375Wire Stories
Best’s Commentary: AM Best Issues FAQ on Its Country Risk Evaluation of China Following Economic Slowdown
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has issued a new commentary on its country risk evaluation process in response to recent concerns about China’s...
- 498News
Watsons Singapore Launches Tru Niagen® Immune, a Groundbreaking Formula for Age Transformation and Immunity Boost
SINGAPORE – Media OutReach Newswire – 24 January 2024 – Tru Niagen® Immune, the latest innovation from the creators of the esteemed...
- 430Wire Stories
InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
- 400Wire Stories
Asia Pacific Cloud Spend Rebounds in Q4, ISG Indexâ„¢ Finds
XaaS spending in Q4 up 10% vs. prior year, while managed services fell 34% ISG forecasts 15% XaaS revenue growth and 4.25%...
